PIPELINE

We actively work with academia and biotech companies to optimize the discovery of therapies for the immune related diseases.  We are investigating the anti-inflammatory activities of series of synthesized compounds. AIBIOS is working on three active programs to resolve unmet medical needs.

Pre-clinical Programs

AIB-301

・Inflammatory Bowel Disease (IBD)

AIB-401

・ CNS Diseases

AIB-501

・ Respiratory Diseases

Discovery/Optimization studies

・Dermatology Diseases

 

・Neuro-degeneration diseases

・Age-related degenerative diseases

© Since 2015 AIBIOS & Co.